Metsera, Inc. MTSR 深 沪
已收盘 08-01 16:00:00 美东时间
34.89
+1.900
+5.76%
华盛通- 最 高35.15
- 今 开31.24
- 成交量 206.20万股
- 最 低 31.01
- 昨 收 32.99
- 总市值 36.63亿
- 52周最高 47.40
- 市盈率 静 --
- 换手率 1.96%
- 52周最低 12.30
- 委 比 26.05%
- 总股本 1.05亿
- 历史最高 47.40
- 量 比 1.06
- 振 幅 12.55%
- 历史最低 12.30
- 每 手 1
- 风险率 6.24%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Metsera shares are trading lower after the company reported worse-than-expected Q2 EPS results.
Metsera shares are trading lower after the company reported worse-than-expected...
07-29 21:18
Metsera Q2 EPS $(0.66) Misses $(0.64) Estimate
Metsera (NASDAQ:MTSR) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.64) by 3.13 percent. This is a 64.52 percent increase over losses of $(1.86) per share from the same
07-29 05:11
ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining ar...
07-28 20:13
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Telomir Pharmaceuticals (NASDAQ:TELO) shares rose 151.2% to $3.04 duri...
07-18 20:07
美股周涨跌榜 | 加密货币概念股SharpLink周涨71%；CoreWeave周内暴跌23.8%，分析师喊话公司估值似乎过高
加密货币股SharpLink周涨71%；MP周涨超41%，公司与美国国防部签署战略合作协议；CoreWeave周内暴跌23.8%，分析师喊话公司估值似乎过高>>
07-12 10:03
Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining around 0.1% on Wednes...
07-09 23:06
美股大行评级 | 潜在涨幅378.93%！aTyr Pharma获富国银行升目标价至25美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1143101010774646784.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 富国银行：维持aTyr Pharma(ATYR)"超配"评级，目标价从17美元升至25美元</p> <p>• 摩根大通：维持Array Technologies(ARRY)"超配"评级，目标价从12美元升至13美元</p>
06-21 08:35
Wells Fargo Initiates Coverage On Metsera with Overweight Rating, Announces Price Target of $65
Wells Fargo analyst Cerena Chen initiates coverage on Metsera (NASDAQ:MTSR) with a Overweight rating and announces Price Target of $65.
06-20 19:45
美股大行评级 | 潜在涨幅434.95%！VNRX获Jones Trading首予"买入"评级，目标价3美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139478829918380033.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Metsera(MTSR)"买入"评级，目标价从56美元升至62美元</p> <p>• 摩根大通：维持Avidity Biosciences(RNA)"超配"评级，目标价从57美元升至59美元</
06-11 09:43
